eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-CRVS-Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. CRVS

‎$‎10.230.58(6.01%)(1D)
• Delayed prices by NASDAQ • in USD
Analyst Forecast
Consensus
Strong Buy
Price Target
30.33
Based on analysts who covered CRVS
Invest in Corvus Pharmaceuticals, Inc.
Today
Create an eToro account to buy CRVS stock on a secure, user-friendly, multi-asset trading platform.
Buy CRVS
Corvus Pharmaceuticals, Inc. CRVS
Buy Corvus Pharmaceuticals, Inc.

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

CRVS Stock Price Chart

‎1.79‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset positive trend

The Corvus Pharmaceuticals, Inc. share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Corvus Pharmaceuticals, Inc. share price today is ‎$‎10.23, reflecting a ‎6.01‎% change over the last 24 hours and ‎8.62‎% over the past week. The current market capitalization of CRVS is ‎$‎860.56M with an average volume in the last three months of 980858.65. The stock has a P/E ratio of -16.56 and a dividend yield of 0%. With the stock’s beta sitting at 1.46
CRVS Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎860.56M
Day’s Range
i
Shows the high and low prices of the day.
‎$‎9.6 - ‎$‎10.32
52W Range
i
Shows the high and low prices of the last year.
‎$‎9.2 - ‎$‎10.32
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
980858.65
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-16.56
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎0
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎10.23
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-0.62
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.46

How can I buy Corvus Pharmaceuticals, Inc. stocks?

To purchase Corvus Pharmaceuticals, Inc.:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Corvus Pharmaceuticals, Inc. (CRVS) page and place an order to buy Corvus Pharmaceuticals, Inc..
Buy CRVS
Looking for more information? Check out our guide on Academy.
What Is Corvus Pharmaceuticals, Inc.?
Corvus Pharmaceuticals Inc is a United States-based clinical-stage biopharmaceutical company focused on developing innovative therapies. Its primary aim is to treat cancer and other serious diseases by activating and harnessing the body’s immune system. The company advances its pipeline through rigorous research and clinical trials.

Addressing challenges in the healthcare sector, specifically biotechnology, Corvus Pharmaceuticals Inc concentrates on targeted immunotherapies. Its work seeks to deliver new treatment options for patients by applying novel scientific approaches to disease management.

Monitor the CRVS share price by adding it to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
CEO
Richard A. Miller, MD
Employees
37
Founded
2014
HQ
South San Francisco, California, US
Med TechNASDAQ
Get Started
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
What Is Leverage and Margin?
What Is Leverage and Margin?
How do leverage and margin work? We explain what leverage is and how investors can use margin and leverage to increase their buying power.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
Go to the Academy >
Invest in Corvus Pharmaceuticals, Inc.
Today
Create an eToro account to buy CRVS stock on a secure, user-friendly, multi-asset trading platform.
Get Started
Buy Corvus Pharmaceuticals, Inc.

FAQ

The current price of CRVS is ‎$‎10.23.
The average price target for Corvus Pharmaceuticals, Inc. is ‎$‎30.33. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Corvus Pharmaceuticals, Inc. based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Corvus Pharmaceuticals, Inc. is ‎$‎860.56M
Based on 3 analysts offering recommendations for CRVS in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
Buy CRVS
English (UK)
DeutschFrançaisPolskiPortuguêsDanskSuomi
EspañolРусскийالعربيةNederlandsSvenskaRomânăItaliano
中文繁體中文NorskČeštinaTiếng ViệtΕλληνικά
Scroll to top